Medical therapy for Cushing's disease.
Various drugs have been employed in the management of pituitary-dependent Cushing's disease. The neuromodulatory compounds used thus far have demonstrated true clinical efficacy only occasionally when employed as sole treatment. Steroid synthesis inhibitors are effective in the majority of cases in a dose-dependent manner. By their ability to correct hypercortisolism and its severe complications quickly, they are suitable for critical cases and in preparation for surgery. The clinical experience with the only glucocorticoid receptor antagonist that can be administered to humans is still too limited to assess its therapeutic validity. No medical strategy can be standardized for this complex condition. Different therapeutic tools should be selected according to the form of disease to be treated (hypothalamic/pituitary) and the peculiar clinical situation of each patient. Combined treatments may achieve better therapeutic efficacy.
Sonino
N
N
Division of Endocrinology, University of Padova, Italy.
Boscaro
M
M
D000311:Adrenal Glands / Q000187:drug effects; D000818:Animals; D003480:Cushing Syndrome / Q000188:drug therapy*; D018491:Dopamine Agonists / Q000627:therapeutic use; D018755:GABA Agonists / Q000627:therapeutic use; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects; D010902:Pituitary Gland / Q000187:drug effects; D012702:Serotonin Antagonists / Q000627:therapeutic use
D018491:Dopamine Agonists; D018755:GABA Agonists; D012702:Serotonin Antagonists